Comar, LLC

Comar, LLC, based in the US, specializes in contract manufacturing, providing tailored packaging and dispensing solutions primarily for health and wellness applications. Founded in 1949 and headquartered in Voorhees, US, Comar, LLC is dedicated to contract manufacturing in the healthcare sector. The company has undergone strategic pivots to enhance its service offerings. Comar was acquired in June 2018 by Morgan Stanley Investment Management from Graham Partners.

Current CEOs are Brian Larkin and Mike Ruggieri. Comar Medical specializes in contract manufacturing, offering a comprehensive array of custom-designed packaging and dispensing solutions aimed at health and wellness applications. Their core product offerings encompass stock, made-to-order, and tailored packaging solutions utilizing advanced molding technologies such as injection molding, injection blow molding, extrusion blow molding, and injection stretch blow molding. These products are crafted to meet the unique demands of clients in the pharmaceutical, diagnostics, and MedTech sectors, ensuring precision and reliability in critical environments.

The company serves a global clientele, focusing on regions with advanced healthcare infrastructures, including North America, Europe, and parts of Asia. Comar Medical generates revenue through a B2B model, primarily partnering with clients in the healthcare sector. The business model is structured around direct transactions with customers, often defined by long-term contracts for customized packaging and dispensing solutions. These agreements may include ongoing supply arrangements and the development of bespoke products to meet specific client requirements.

Pricing structures are tailored according to the complexity and customization of products, with flagship offerings designed to deliver value while remaining competitive in the market. Comar Medical prioritizes collaboration and responsiveness to foster strong customer relationships that support business growth. Comar, LLC is focused on developing new products, leveraging recent funding to enhance its design and manufacturing capabilities. The company aims to expand into new markets, particularly targeting increased penetration in Europe and parts of Asia by 2025.

Recent funding, following the acquisition in June 2018, will support these product launches and market expansion initiatives.